| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
|
Eurofins Scientific
Euronext : ERF Luxembourg, Luxembourg website |
Life Science | 7,342 | 99 | 98 | 1 |
|
|
Pfizer
NYSE : PFE New York, New York, United States website |
Life Science | 63,627 | 62 | 44 | 18 |
|
|
Roche
SIX Swiss Exchange : RHHBY Basel, Switzerland website |
Life Science | 62,801 | 44 | 42 | 2 |
|
|
Lilly
NYSE : LLY Indianapolis, Indiana, United States website |
Life Science | 34,124 | 45 | 35 | 10 |
|
|
Bausch Health
NYSE : BHC Laval, Quebec, Canada website |
Life Science | 8,757 | 45 | 35 | 10 |
|
|
Merck
NYSE : MRK Rahway, New Jersey, United States website |
Life Science | 64,168 | 42 | 35 | 7 |
|
|
Calibre Scientific
PE Backed Holland, Ohio, United States website |
Life Science | - | 35 | 35 | - |
|
|
Novartis
NYSE : NVS Basel, Switzerland website |
Life Science | 46,660 | 41 | 33 | 8 |
|
|
GSK
London Stock Exchange : GSK Brentford, United Kingdom website |
Life Science | 46,687 | 57 | 33 | 24 |
|
|
Charles River Laboratories International
NYSE : CRL Wilmington, Massachusetts, United States website |
Life Science | 4,129 | 34 | 31 | 3 |
|
|
Azenta
NASDAQ : AZTA Burlington, Massachusetts, United States website |
Life Science | 656 | 29 | 24 | 5 |
|
|
Bristol-Myers Squibb
NYSE : BMY Princeton, New Jersey, United States website |
Life Science | 45,006 | 37 | 24 | 13 |
|
|
Gilead Sciences
NASDAQ : GILD Foster City, California, United States website |
Life Science | 28,754 | 27 | 24 | 3 |
|
|
AstraZeneca
NASDAQ : AZN Cambridge, United Kingdom website |
Life Science | 54,073 | 33 | 22 | 11 |
|
|
Amgen
NASDAQ : AMGN Thousand Oaks, California, United States website |
Life Science | 28,190 | 21 | 21 | - |
|
|
Celgene Corp.
Acquired Summit, New Jersey, United States website |
Life Science | 13,003 | 18 | 15 | 3 |
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
